<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22022281</PMID><DateCompleted><Year>2012</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1553-7404</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>10</Issue><PubDate><Year>2011</Year><Month>Oct</Month></PubDate></JournalIssue><Title>PLoS genetics</Title><ISOAbbreviation>PLoS Genet</ISOAbbreviation></Journal><ArticleTitle>Macroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice.</ArticleTitle><Pagination><StartPage>e1002321</StartPage><MedlinePgn>e1002321</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1002321</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgen.1002321</ELocationID><Abstract><AbstractText>Altered protein homeostasis underlies degenerative diseases triggered by misfolded proteins, including spinal and bulbar muscular atrophy (SBMA), a neuromuscular disorder caused by a CAG/glutamine expansion in the androgen receptor. Here we show that the unfolded protein response (UPR), an ER protein quality control pathway, is induced in skeletal muscle from SBMA patients, AR113Q knock-in male mice, and surgically denervated wild-type mice. To probe the consequence of UPR induction, we deleted CHOP (C/EBP homologous protein), a transcription factor induced following ER stress. CHOP deficiency accentuated atrophy in both AR113Q and surgically denervated muscle through activation of macroautophagy, a lysosomal protein quality control pathway. Conversely, impaired autophagy due to Beclin-1 haploinsufficiency decreased muscle wasting and extended lifespan of AR113Q males, producing a significant and unexpected amelioration of the disease phenotype. Our findings highlight critical cross-talk between the UPR and macroautophagy, and they indicate that autophagy activation accentuates aspects of the SBMA phenotype.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pathology, The University of Michigan Medical School, Ann Arbor, Michigan, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Adrienne M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Adachi</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Katsuno</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Sobue</LastName><ForeName>Gen</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Zhenyu</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Robins</LastName><ForeName>Diane M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 CA069568</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS055746</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS060123</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 CA69568</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Genet</MedlineTA><NlmUniqueID>101239074</NlmUniqueID><ISSNLinking>1553-7390</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051017">Apoptosis Regulatory Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071186">Beclin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C115010">Becn1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497250">Ddit3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-12-7</RegistryNumber><NameOfSubstance UI="D051742">Transcription Factor CHOP</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051017" MajorTopicYN="N">Apoptosis Regulatory Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071186" MajorTopicYN="N">Beclin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003714" MajorTopicYN="N">Denervation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055879" MajorTopicYN="N">Gene Knock-In Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057895" MajorTopicYN="N">Haploinsufficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012584" MajorTopicYN="N">Sciatic Nerve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051742" MajorTopicYN="N">Transcription Factor CHOP</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056811" MajorTopicYN="N">Unfolded Protein Response</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22022281</ArticleId><ArticleId IdType="pmc">PMC3192827</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1002321</ArticleId><ArticleId IdType="pii">PGENETICS-D-11-00382</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007;30:575&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pubmed">17417937</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci. 2000;23:217&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">10845064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Fischbeck KH. Triplet repeat expansion in neuromuscular disease. Muscle Nerve. 2000;23:843&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">10842259</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Waza M, Banno H, Suzuki K, et al. Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA). Exp Neurol 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16513111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperfeld AD, Karitzky J, Brummer D, Schreiber H, Haussler J, et al. X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol. 2002;59:1921&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pubmed">12470181</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain. 1989;112(Pt 1):209&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen ES, O'Brien CJ, Wang H, Jenkins SC, Holder L, et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci. 2004;24:4778&#x2013;4786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35:843&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol. 2009;65:140&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">19259967</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, et al. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20691641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, et al. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol. 2011;10:140&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056353</ArticleId><ArticleId IdType="pubmed">21216197</ArticleId></ArticleIdList></Reference><Reference><Citation>Albertelli MA, Scheller A, Brogley M, Robins DM. Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol. 2006;20:1248&#x2013;1260.</Citation><ArticleIdList><ArticleId IdType="pubmed">16601069</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, et al. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest. 2006;116:2663&#x2013;2672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Dadgar N, Albertelli M, Scheller A, Albin RL, et al. Abnormalities of Germ Cell Maturation and Sertoli Cell Cytoskeleton in Androgen Receptor 113 CAG Knock-In Mice Reveal Toxic Effects of the Mutant Protein. Am J Pathol. 2006;168:195&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592669</ArticleId><ArticleId IdType="pubmed">16400023</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, et al. Overexpressioin of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A 2007</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, Stack C, Kong L, Musaro A, Adachi H, et al. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron. 2009;63:316&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735765</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994;22:3181&#x2013;3186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC310294</ArticleId><ArticleId IdType="pubmed">8065934</ArticleId></ArticleIdList></Reference><Reference><Citation>Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, et al. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet. 2000;9:267&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">10607837</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemi-Esfarjani P, Trifiro MA, Pinsky L. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet. 1995;4:523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">7633399</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, et al. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet. 1993;5:184&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">8252045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Harmison G, Strand AD, Olson JM, Fischbeck KH. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet. 2002;11:1967&#x2013;1976.</Citation><ArticleIdList><ArticleId IdType="pubmed">12165558</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A, Taylor JP, Taye AA, Robitschek J, Li M, et al. CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet. 2000;9:2197&#x2013;2202.</Citation><ArticleIdList><ArticleId IdType="pubmed">10958659</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Wang AM, Robins DM, Lieberman AP. Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice. Dis Model Mech. 2009;2:500&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2737058</ArticleId><ArticleId IdType="pubmed">19692580</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Minamiyama M, Waza M, Tokui K, et al. Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. J Neurosci. 2006;26:12106&#x2013;12117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6675422</ArticleId><ArticleId IdType="pubmed">17122035</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccioni F, Pinton P, Simeoni S, Pozzi P, Fascio U, et al. Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. Faseb J. 2002;16:1418&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pubmed">12205033</ArticleId></ArticleIdList></Reference><Reference><Citation>Szebenyi G, Morfini GA, Babcock A, Gould M, Selkoe K, et al. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron. 2003;40:41&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">14527432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S, Harmison GG, Meyertholen K, Pennuto M, Burnett BG, et al. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum Mol Genet. 2009;18:27&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2644643</ArticleId><ArticleId IdType="pubmed">18824496</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas M, Harrell JM, Morishima Y, Peng HM, Pratt WB, et al. Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction. Hum Mol Genet. 2006;15:1876&#x2013;1883.</Citation><ArticleIdList><ArticleId IdType="pubmed">16644868</ArticleId></ArticleIdList></Reference><Reference><Citation>Waza M, Adachi H, Katsuno M, Minamiyama M, Sang C, et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med. 2005;11:1088&#x2013;1095.</Citation><ArticleIdList><ArticleId IdType="pubmed">16155577</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi H, Waza M, Tokui K, Katsuno M, Minamiyama M, et al. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J Neurosci. 2007;27:5115&#x2013;5126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6672370</ArticleId><ArticleId IdType="pubmed">17494697</ArticleId></ArticleIdList></Reference><Reference><Citation>Morishima Y, Wang AM, Yu Z, Pratt WB, Osawa Y, et al. CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins. Hum Mol Genet. 2008;17:3942&#x2013;3952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605787</ArticleId><ArticleId IdType="pubmed">18784277</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang AM, Morishima Y, Clapp KM, Peng HM, Pratt WB, et al. Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation. J Biol Chem. 2010;285:15714&#x2013;15723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2871437</ArticleId><ArticleId IdType="pubmed">20348093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ron D. Translational control in the endoplasmic reticulum stress response. J Clin Invest. 2002;110:1383&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151821</ArticleId><ArticleId IdType="pubmed">12438433</ArticleId></ArticleIdList></Reference><Reference><Citation>Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8:519&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">17565364</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas M, Yu Z, Dadgar N, Varambally S, Yu J, et al. The unfolded protein response modulates toxicity of the expanded glutamine androgen receptor. J Biol Chem. 2005;280:21264&#x2013;21271.</Citation><ArticleIdList><ArticleId IdType="pubmed">15799970</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 1998;12:982&#x2013;995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC316680</ArticleId><ArticleId IdType="pubmed">9531536</ArticleId></ArticleIdList></Reference><Reference><Citation>Southwood CM, Garbern J, Jiang W, Gow A. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron. 2002;36:585&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4603660</ArticleId><ArticleId IdType="pubmed">12441049</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennuto M, Tinelli E, Malaguti M, Del Carro U, D'Antonio M, et al. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron. 2008;57:393&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2267889</ArticleId><ArticleId IdType="pubmed">18255032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostrominova TY, Dow DE, Dennis RG, Miller RA, Faulkner JA. Comparison of gene expression of 2-mo denervated, 2-mo stimulated-denervated, and control rat skeletal muscles. Physiol Genomics. 2005;22:227&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">15840640</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass DJ. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol. 2003;5:87&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">12563267</ArticleId></ArticleIdList></Reference><Reference><Citation>Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007;6:458&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">18054315</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie HL, Cho MS, Holder L, Liu Y, Tsvetkov AS, et al. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet. 2009;18:1937&#x2013;1950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Thielen P, Matus S, Nassif M, Court F, et al. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009;23:2294&#x2013;2306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758741</ArticleId><ArticleId IdType="pubmed">19762508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, et al. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 2007;14:230&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">16794605</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata M, Hino S, Saito A, Morikawa K, Kondo S, et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol. 2006;26:9220&#x2013;9231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1698520</ArticleId><ArticleId IdType="pubmed">17030611</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100:15077&#x2013;15082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC299911</ArticleId><ArticleId IdType="pubmed">14657337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y, Wang QJ, Li X, Yan Y, Backer JM, et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nat Cell Biol. 2009;11:468&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2664389</ArticleId><ArticleId IdType="pubmed">19270693</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112:1809&#x2013;1820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC297002</ArticleId><ArticleId IdType="pubmed">14638851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouroku Y, Fujita E, Jimbo A, Kikuchi T, Yamagata T, et al. Polyglutamine aggregates stimulate ER stress signals and caspase-12 activation. Hum Mol Genet. 2002;11:1505&#x2013;1515.</Citation><ArticleIdList><ArticleId IdType="pubmed">12045204</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 2002;16:1345&#x2013;1355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC186318</ArticleId><ArticleId IdType="pubmed">12050113</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnemolla A, Fossale E, Agostoni E, Michelazzi S, Calligaris R, et al. Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease. J Biol Chem. 2009;284:18167&#x2013;18173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2709382</ArticleId><ArticleId IdType="pubmed">19433866</ArticleId></ArticleIdList></Reference><Reference><Citation>Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 2000;287:664&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pubmed">10650002</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007;447:859&#x2013;863.</Citation><ArticleIdList><ArticleId IdType="pubmed">17568747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004;36:585&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">15146184</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol. 2008;4:295&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2635566</ArticleId><ArticleId IdType="pubmed">18391949</ArticleId></ArticleIdList></Reference><Reference><Citation>Renna M, Jimenez-Sanchez M, Sarkar S, Rubinsztein DC. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem. 2010;285:11061&#x2013;11067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856980</ArticleId><ArticleId IdType="pubmed">20147746</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>